Literature DB >> 18071911

Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells.

Chiara Marconi1, Francesca Bianchini, Antonella Mannini, Gabriele Mugnai, Salvatore Ruggieri, Lido Calorini.   

Abstract

The aim of this study was to investigate whether tumor cells as well as tumor-associated macrophages (TAMs) contribute to the generation of protease activities essential to tumor cell invasiveness, such as matrix metalloproteinase 2 and 9 (MMP-2 and MMP-9), and the urokinase-type plasminogen activator (uPA) and uPA receptor (uPAR). We found that the enhanced invasiveness through Matrigel-coated filters of B16 murine melanoma cells stimulated with IFNgamma was associated with an higher expression of uPAR and MMP-9 in these cells. Moreover, treatment with anti-MMP-9 or anti-uPAR monoclonal antibodies abrogated the increase of invasiveness in IFNgamma-stimulated melanoma cells, suggesting a cooperation of uPA system and MMP-9 in cytokine-stimulated invasiveness. Invasiveness through Matrigel was also enhanced in B16 melanoma cells exposed to a medium conditioned by TAMs, represented in our experimental model by thioglycollate-elicited macrophages co-cultivated with melanoma cells. Macrophages isolated from these co-cultures were found to express higher levels of uPAR and MMP-9 compared to macrophage cultures alone, and the pro-invasive activity of the co-culture-conditioned medium was abrogated by anti-MMP-9 monoclonal antibodies, but not anti-uPAR monoclonal antibodies. Furthermore, the enhanced uPAR and MMP-9 expression in macrophages co-cultivated with tumor cells seems a rather specific phenomenon, generated through a cell-to-cell contact mechanism. On the whole, our data point to a cooperation between tumor cells and macrophages elicited by tumor cells themselves in generating key enzymes essential in the promotion of tumor invasiveness, such as uPAR and MMP-9.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18071911     DOI: 10.1007/s10585-007-9136-0

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  33 in total

1.  Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor.

Authors:  James E Thompson; Rose M Cubbon; Richard T Cummings; Linda S Wicker; Robert Frankshun; Barry R Cunningham; Patricia M Cameron; Peter T Meinke; Nigel Liverton; Youmin Weng; Julie A DeMartino
Journal:  Bioorg Med Chem Lett       Date:  2002-04-22       Impact factor: 2.823

2.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

Review 3.  Matrix metalloproteinases in human melanoma.

Authors:  U B Hofmann; J R Westphal; G N Van Muijen; D J Ruiter
Journal:  J Invest Dermatol       Date:  2000-09       Impact factor: 8.551

4.  Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis.

Authors:  K Saito; S Takeha; K Shiba; S Matsuno; T Sorsa; H Nagura; H Ohtani
Journal:  Int J Cancer       Date:  2000-04-01       Impact factor: 7.396

5.  Platelet-activating factor (PAF) is the effector of IFN gamma-stimulated invasiveness and motility in a B16 melanoma line.

Authors:  Anna Fallani; Lido Calorini; Antonella Mannini; Silvia Gabellieri; Gabriele Mugnai; Salvatore Ruggieri
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-10-18       Impact factor: 3.072

6.  Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice.

Authors:  Silvia D'Alessio; Francesca Margheri; Marco Pucci; Angela Del Rosso; Brett P Monia; Mauro Bologna; Carlo Leonetti; Marco Scarsella; Gabriella Zupi; Gabriella Fibbi; Mario Del Rosso
Journal:  Int J Cancer       Date:  2004-05-20       Impact factor: 7.396

7.  Tyrphostins are inhibitors of guanylyl and adenylyl cyclases.

Authors:  Mahaboobi Jaleel; Avinash R Shenoy; Sandhya S Visweswariah
Journal:  Biochemistry       Date:  2004-06-29       Impact factor: 3.162

8.  Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion.

Authors:  Mikael Björklund; Pia Heikkilä; Erkki Koivunen
Journal:  J Biol Chem       Date:  2004-04-30       Impact factor: 5.157

9.  Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer.

Authors:  Shashi R Harvey; Thelma C Hurd; Gabor Markus; Maisie I Martinick; Remedios M Penetrante; Dongfeng Tan; Preeti Venkataraman; Nisha DeSouza; Sheila N J Sait; Deborah L Driscoll; John F Gibbs
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

Review 10.  Multiple pathways of cell invasion are regulated by multiple families of serine proteases.

Authors:  Mario Del Rosso; Gabriella Fibbi; Marco Pucci; Silvia D'Alessio; Angela Del Rosso; Lucia Magnelli; Vincenzo Chiarugi
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

View more
  19 in total

1.  Monitoring mmp-9 gene expression in stromal cells using a novel transgenic mouse model.

Authors:  Katherine Biron-Pain; Yves St-Pierre
Journal:  Cell Mol Life Sci       Date:  2011-08-11       Impact factor: 9.261

Review 2.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

3.  Potentiation of tumor cell invasion by co-culture with monocytes accompanying enhanced production of matrix metalloproteinase and fibronectin.

Authors:  Go Kamoshida; Ayaka Matsuda; Risa Miura; Yuri Takashima; Arisa Katsura; Tsutomu Tsuji
Journal:  Clin Exp Metastasis       Date:  2012-09-29       Impact factor: 5.150

Review 4.  Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target.

Authors:  Eleonore Fröhlich
Journal:  Cell Mol Life Sci       Date:  2010-08-05       Impact factor: 9.261

Review 5.  Role of tumor-associated macrophages in the progression of hepatocellular carcinoma.

Authors:  Ken Shirabe; Yohei Mano; Jun Muto; Rumi Matono; Takashi Motomura; Takeo Toshima; Kazuki Takeishi; Hidekaki Uchiyama; Tomoharu Yoshizumi; Akinobu Taketomi; Masaru Morita; Shunichi Tsujitani; Yoshihisa Sakaguchi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-11-25       Impact factor: 2.549

Review 6.  Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology.

Authors:  George S Karagiannis; Maria P Pavlou; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2010-09-16       Impact factor: 6.603

7.  Melanoma-derived conditioned media efficiently induce the differentiation of monocytes to macrophages that display a highly invasive gene signature.

Authors:  Tao Wang; Yingbin Ge; Min Xiao; Alfonso Lopez-Coral; Rikka Azuma; Rajasekharan Somasundaram; Gao Zhang; Zhi Wei; Xiaowei Xu; Frank J Rauscher; Meenhard Herlyn; Russel E Kaufman
Journal:  Pigment Cell Melanoma Res       Date:  2012-07       Impact factor: 4.693

8.  Macrophages in skin melanoma-the key element in melanomagenesis.

Authors:  Malgorzata Pieniazek; Rafal Matkowski; Piotr Donizy
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

Review 9.  Melanoma and the tumor microenvironment.

Authors:  Jessie Villanueva; Meenhard Herlyn
Journal:  Curr Oncol Rep       Date:  2008-09       Impact factor: 5.075

10.  Platelet-derived growth factor-C (PDGF-C) induces anti-apoptotic effects on macrophages through Akt and Bad phosphorylation.

Authors:  Dain Son; Yi Rang Na; Eung-Soo Hwang; Seung Hyeok Seok
Journal:  J Biol Chem       Date:  2014-01-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.